Search Results for "Vinu Arumugham"
An mRNA Vaccine against SARS-CoV-2 Preliminary Report—A Researcher Reacts
Vinu Arumugham responds to the preliminary report on Moderna’s mRNA COVID-19 vaccine, pointing out with examples such as the Pandemrix induced narcolepsy disaster and the failed ebola vaccine, that the whole idea of depending on testing alone for safety, is UNACCEPTABLE.
Autoepitopes (22 of 27) in rheumatoid arthritis differ from vaccine antigens by a single amino acid residue, ideal for low affinity self-reactive T cell mediated autoimmunity and a…
Residual animal, plant, fungal, aeroallergen proteins (non-target proteins in general) in vaccines cause numerous disorders including rheumatoid arthritis. The solution is to immediately remove all non-target antigens from vaccines using technologies such as affinity chromatography.